Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Teva announces top-line results from GALA Phase III trial evaluating a new dosage for glatiramer acetate given three times weekly for relapsing-remitting multiple sclerosis
Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
Efficacy and safety study of RPC1063 in relapsing multiple sclerosis patients
Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis.
Symptom changes in multiple sclerosis following psychological interventions: a systematic review.
Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.
American Academy of Neurology Annual Meeting
Impact of MS during the critical window of brain development.
Genzyme presents second Phase III study of once-daily oral AUBAGIO® (teriflunomide) confirming significant impact on disability
Antigen-specific tolerance by autologous myelin Peptide-coupled cells: a phase 1 trial in multiple sclerosis.
Gender identity disorders and multiple sclerosis risk: A national record-linkage study.
One calcitriol dose transiently increases Helios(+)FoxP3(+) T cells and ameliorates autoimmune demyelinating disease.
The Relative Importance of Baseline Pain, Fatigue, Sleep and Physical Activity: Predicting Change in Depression in Adults with Multiple Sclerosis.
JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab.
Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes.
Ustekinumab success in refractory Crohn’s disease
Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators.
EMD Serono
Intermittent self-catheterisation in MS.
Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor.
Receptos to deliver scientific presentations about RPC1063 at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

Pages